| Patient | Florence Nightingale |
|---|---|
| Date of birth | 1820-05-12 |
| Identifiers | MRN HR-NI004-SYN-TD; SSN (made up) 000-04-9271 |
| Document date | 2026-11-01 |
| Author | Isobel Marchetti, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for nearly three years of exhausting fatigue that worsens after exertion. Concerns: Nearly three years of exhausting fatigue since a severe febrile illness on an overseas deployment, with crashes lasting days after any push of work; Lightheaded with a racing heart when standing in a line or at the stove; Wants above all to keep doing her statistical and policy work, even if much of it has to be done from her sofa or bed. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a day | One to two tablets by mouth every 6 hours as needed; no more than 3 g a day | Oral route | 1857-11-03 | active | S |
| Cholecalciferol (vitamin D3) 50 mcg (2,000 units) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1858-03-16 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Ten-minute passive standing test (NASA lean test): heart rate 66/min supine and 92/min at 10 minutes (rise of 26/min); blood pressure 106/68 supine and 102/70 standing; lightheadedness and leg mottling from minute 6; no orthostatic hypotension and below the 30/min threshold for postural tachycardia syndrome | 1858-03-02 to 1858-03-02 | completed | S |
| Repeat ten-minute passive standing test: heart rate 68/min supine and 86/min at 10 minutes (rise of 18/min); blood pressure 108/70 supine and 106/72 standing; mild lightheadedness only after minute 8 | 1858-09-14 to 1858-09-14 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1842-09-20 | Hepatitis B vaccine, adult three-dose series completed | completed | S |
| 1853-09-13 | Tdap vaccine | completed | S |
| 1857-10-20 | Influenza vaccine, 1857-1858 season | completed | S |
| 1858-10-12 | Influenza vaccine, 1858-1859 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| May 1855 | Crimean fever at Balaclava: dangerously ill and near death, then a slow and painful recovery; she called it typhus | D (CLM-0003) |
| May 1855 | Retrospective interpretation of the Crimean fever as brucellosis, without laboratory confirmation (possible, not established) | R (CLM-0004) |
| August 1857 | Overwork and failing health during the army health commission, with rest at Malvern, a collapse with cardiac symptoms, then nausea, insomnia, and palpitations; took to her bed or couch on doctors' orders but kept working | D (CLM-0006) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| Nearly three years of exhausting fatigue since a severe febrile illness on an overseas deployment, with crashes lasting days after any push of work | active | S |
| Lightheaded with a racing heart when standing in a line or at the stove | active | S |
| Wants above all to keep doing her statistical and policy work, even if much of it has to be done from her sofa or bed | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 12.9 on 1858-03-02; Leukocytes [#/volume] in Blood by Automated count 5.8 on 1858-03-02; Platelets [#/volume] in Blood by Automated count 246 on 1858-03-02; Sodium [Moles/volume] in Serum or Plasma 139 on 1858-03-02; Potassium [Moles/volume] in Serum or Plasma 4.2 on 1858-03-02; Creatinine [Mass/volume] in Serum or Plasma 0.72 on 1858-03-02; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1853)/1.73 sq M 110 on 1858-03-02; Glucose [Mass/volume] in Serum or Plasma 86 on 1858-03-02; Calcium [Mass/volume] in Serum or Plasma 9.3 on 1858-03-02; Albumin [Mass/volume] in Serum or Plasma 4.3 on 1858-03-02; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 16 on 1858-03-02; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19 on 1858-03-02; Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 68 on 1858-03-02; Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 on 1858-03-02; Phosphate [Mass/volume] in Serum or Plasma 3.6 on 1858-03-02; Erythrocyte [Sedimentation Rate] in Blood by Westergren method 8 on 1858-03-02; C reactive protein [Mass/volume] in Serum or Plasma 1.2 on 1858-03-02; Thyrotropin [Units/volume] in Serum or Plasma 1.9 on 1858-03-02; Hemoglobin A1c/Hemoglobin.total in Blood 5.1 on 1858-03-02; Ferritin [Mass/volume] in Serum or Plasma 48 on 1858-03-02; Tissue transglutaminase IgA Ab [Units/volume] in Serum 1 on 1858-03-02; Creatine kinase [Enzymatic activity/volume] in Serum or Plasma 92 on 1858-03-02; Cortisol [Mass/volume] in Serum or Plasma 14.2 on 1858-03-02; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 410 on 1858-03-02; Folate [Mass/volume] in Serum or Plasma 12.4 on 1858-03-02; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 on 1858-09-14; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 1858-10-12; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 on 1858-10-12; PROMIS fatigue - version 1.0 Tscore 64 on 1858-09-14; PROMIS physical function - version 1.0 Tscore 38 on 1858-09-14; Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 on 1858-09-14; Total score [AUDIT-C] 1 on 1858-10-12 [S]
Strengths and supports: Supports: a small team of trusted colleagues who visit her at home to work, and a wide network of correspondents [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Myalgic encephalomyelitis/chronic fatigue syndrome, post-infectious, moderate severity, with orthostatic intolerance; synthetic modern diagnosis by NICE and IOM criteria, linked to her documented Crimean fever and decades of illness, which are only retrospectively and disputedly read as ME/CFS | active | confirmed | G93.32 | S — Synthetic diagnosis made by clinical criteria after exclusion tests in the modern episode; the historical reading of her illness as ME/CFS remains R and disputed. |
| Personal history of brucellosis diagnosed by serology during an overseas field-hospital deployment and treated with six weeks of doxycycline and rifampin; no evidence of relapse | active | confirmed | Z86.19 | S — Synthetic history echoing the disputed retrospective interpretation of her Crimean fever as brucellosis; not a historical diagnosis. |
| Vitamin D deficiency | active | confirmed | E55.9 | S — Synthetic finding on the intake tests, reviewed at the two-week visit. |
| Acute viral upper respiratory infection with a short ME/CFS flare, resolved without antibiotics | resolved | confirmed | J06.9 | S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1858-03-02 | Hemoglobin [Mass/volume] in Blood | 12.9 | g/dL | 11.6-15 g/dL | Normal | S |
| 1858-03-02 | Leukocytes [#/volume] in Blood by Automated count | 5.8 | 10*3/uL | 3.4-10.8 10*3/uL | Normal | S |
| 1858-03-02 | Platelets [#/volume] in Blood by Automated count | 246 | 10*3/uL | 150-450 10*3/uL | Normal | S |
| 1858-03-02 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1858-03-02 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1858-03-02 | Creatinine [Mass/volume] in Serum or Plasma | 0.72 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1858-03-02 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1853)/1.73 sq M | 110 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1858-03-02 | Glucose [Mass/volume] in Serum or Plasma | 86 | mg/dL | 70-99 mg/dL | Normal | S |
| 1858-03-02 | Calcium [Mass/volume] in Serum or Plasma | 9.3 | mg/dL | 8.6-10.2 mg/dL | Normal | S |
| 1858-03-02 | Albumin [Mass/volume] in Serum or Plasma | 4.3 | g/dL | 3.5-5.2 g/dL | Normal | S |
| 1858-03-02 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 16 | U/L | 7-35 U/L | Normal | S |
| 1858-03-02 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 19 | U/L | 10-35 U/L | Normal | S |
| 1858-03-02 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 68 | U/L | 44-121 U/L | Normal | S |
| 1858-03-02 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 1858-03-02 | Phosphate [Mass/volume] in Serum or Plasma | 3.6 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1858-03-02 | Erythrocyte [Sedimentation Rate] in Blood by Westergren method | 8 | mm/h | <=20 mm/h | Normal | S |
| 1858-03-02 | C reactive protein [Mass/volume] in Serum or Plasma | 1.2 | mg/L | <=5 mg/L | Normal | S |
| 1858-03-02 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1858-03-02 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.1 | % | <=5.6% | Normal | S |
| 1858-03-02 | Ferritin [Mass/volume] in Serum or Plasma | 48 | ng/mL | 30-150 ng/mL | Normal | S |
| 1858-03-02 | Tissue transglutaminase IgA Ab [Units/volume] in Serum | 1 | U/mL | <=3.9 U/mL | Normal | S |
| 1858-03-02 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma | 92 | U/L | 26-192 U/L | Normal | S |
| 1858-03-02 | Cortisol [Mass/volume] in Serum or Plasma | 14.2 | ug/dL | 6.2-19.4 ug/dL | Normal | S |
| 1858-03-02 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1858-03-02 | Folate [Mass/volume] in Serum or Plasma | 12.4 | ng/mL | >=5.9 ng/mL | Normal | S |
| 1858-03-02 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 17 | ng/mL | 30-100 ng/mL | Low | S |
| 1858-03-02 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 1858-03-02 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S | ||
| 1858-03-02 | PROMIS fatigue - version 1.0 Tscore | 71 | {score} | S | ||
| 1858-03-02 | PROMIS physical function - version 1.0 Tscore | 32 | {score} | S | ||
| 1858-03-02 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | {score} | S | ||
| 1858-06-01 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 1858-06-01 | PROMIS fatigue - version 1.0 Tscore | 67 | {score} | S | ||
| 1858-06-01 | PROMIS physical function - version 1.0 Tscore | 35 | {score} | S | ||
| 1858-06-01 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 1858-09-14 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 34 | ng/mL | 30-100 ng/mL | Normal | S |
| 1858-09-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 1858-09-14 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 4 | {score} | S | ||
| 1858-09-14 | PROMIS fatigue - version 1.0 Tscore | 64 | {score} | S | ||
| 1858-09-14 | PROMIS physical function - version 1.0 Tscore | 38 | {score} | S | ||
| 1858-09-14 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S | ||
| 1858-10-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1858-10-12 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | {score} | S | ||
| 1858-10-12 | Total score [AUDIT-C] | 1 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1858-03-02 | Body height | 170 | cm | S |
| 1858-03-02 | Body weight | 55 | kg | S |
| 1858-03-02 | Body mass index (BMI) [Ratio] | 19 | kg/m2 | S |
| 1858-03-02 | Systolic blood pressure | 104 | mm[Hg] | S |
| 1858-03-02 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1858-03-02 | Heart rate | 78 | /min | S |
| 1858-03-02 | Respiratory rate | 14 | /min | S |
| 1858-03-02 | Body temperature | 36.6 | Cel | S |
| 1858-03-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1858-03-16 | Body height | 170 | cm | S |
| 1858-03-16 | Body weight | 55.2 | kg | S |
| 1858-03-16 | Body mass index (BMI) [Ratio] | 19.1 | kg/m2 | S |
| 1858-03-16 | Systolic blood pressure | 106 | mm[Hg] | S |
| 1858-03-16 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1858-03-16 | Heart rate | 76 | /min | S |
| 1858-03-16 | Respiratory rate | 14 | /min | S |
| 1858-03-16 | Body temperature | 36.5 | Cel | S |
| 1858-03-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1858-06-01 | Body height | 170 | cm | S |
| 1858-06-01 | Body weight | 55.6 | kg | S |
| 1858-06-01 | Body mass index (BMI) [Ratio] | 19.2 | kg/m2 | S |
| 1858-06-01 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1858-06-01 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1858-06-01 | Heart rate | 74 | /min | S |
| 1858-06-01 | Respiratory rate | 14 | /min | S |
| 1858-06-01 | Body temperature | 36.6 | Cel | S |
| 1858-06-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1858-09-14 | Body height | 170 | cm | S |
| 1858-09-14 | Body weight | 56 | kg | S |
| 1858-09-14 | Body mass index (BMI) [Ratio] | 19.4 | kg/m2 | S |
| 1858-09-14 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1858-09-14 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1858-09-14 | Heart rate | 72 | /min | S |
| 1858-09-14 | Respiratory rate | 14 | /min | S |
| 1858-09-14 | Body temperature | 36.6 | Cel | S |
| 1858-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1858-07-20 | Body height | 170 | cm | S |
| 1858-07-20 | Body weight | 55.4 | kg | S |
| 1858-07-20 | Body mass index (BMI) [Ratio] | 19.2 | kg/m2 | S |
| 1858-07-20 | Systolic blood pressure | 102 | mm[Hg] | S |
| 1858-07-20 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 1858-07-20 | Heart rate | 92 | /min | S |
| 1858-07-20 | Respiratory rate | 16 | /min | S |
| 1858-07-20 | Body temperature | 37.6 | Cel | S |
| 1858-07-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1858-10-12 | Body height | 170 | cm | S |
| 1858-10-12 | Body weight | 56.1 | kg | S |
| 1858-10-12 | Body mass index (BMI) [Ratio] | 19.4 | kg/m2 | S |
| 1858-10-12 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1858-10-12 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1858-10-12 | Heart rate | 72 | /min | S |
| 1858-10-12 | Respiratory rate | 14 | /min | S |
| 1858-10-12 | Body temperature | 36.6 | Cel | S |
| 1858-10-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1858-03-02 | New patient visit for nearly three years of exhausting fatigue that worsens after exertion | finished | S |
| 1858-03-16 | Two-week review of exclusion tests, ME/CFS diagnosis and care plan, and infectious diseases consultation | finished | S |
| 1858-06-01 | Three-month ME/CFS energy management review | finished | S |
| 1858-09-14 | Six-month ME/CFS care plan review | finished | S |
| 1858-07-20 | Same-day sick visit for a cold with an ME/CFS flare | finished | S |
| 1858-10-12 | Adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Diagnose ME/CFS by clinical criteria after exclusion tests, explain that it is a real illness with no diagnostic test, and give her a written care and support plan, including a flare plan | completed | GL-NICE-MECFS-2021, GL-CDC-MECFS | S |
| Energy management led by the patient: an activity and symptom diary, planned rest before and between tasks, work broken into short blocks, and heart-rate awareness; no graded exercise therapy or fixed increases in activity | completed | GL-NICE-MECFS-2021, GL-CDC-MECFS, GL-MAYO-MECFS-2023 | S |
| Infectious diseases consultation to look for relapsed or focal brucellosis or another persisting infection before attributing her symptoms to ME/CFS | completed | GL-NICE-MECFS-2021, GL-CDC-BRUC, GL-BRUC-2005 | S |
| Orthostatic intolerance measures: 2 to 2.5 L of fluid a day, more salt with meals, waist-high compression garments, and tasks done seated or reclined; repeat the standing test at six months | completed | GL-NICE-MECFS-2021, GL-MAYO-MECFS-2023 | S |
| Sleep, pain, and cognitive symptom care: a regular sleep window with rest periods kept short, acetaminophen as needed, no sedatives or opioids, and memory aids for work | completed | GL-NICE-MECFS-2021, GL-CDC-MECFS | S |
| Vitamin D repletion with cholecalciferol 2,000 units daily, rechecked after about three months | completed | GL-NICE-MECFS-2021 | S |
| Review the care plan at every visit, with PHQ-9, PROMIS fatigue and physical function scores, and a pain score; primary care review at least yearly and more often while the plan is new | completed | GL-NICE-MECFS-2021 | S |
| Workplace adjustments: home working, a reclined workstation, flexible hours, and meetings by video or at her home | completed | GL-NICE-MECFS-2021, GL-CDC-MECFS | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Agree an energy management plan with a stable baseline and no more than one crash a month by the six-month review | 1858-09-14 | completed | One flare in three months, after a cold; no crash from overexertion since the summer | S |
| Keep working within her energy limits, aiming for four hours a day in planned blocks by the six-month review | 1858-09-14 | completed | Working four to five hours a day in 45-minute blocks with rest between | S |
| Fewer orthostatic symptoms with fluids, salt, compression, and seated or reclined tasks by the three-month review | 1858-06-01 | completed | Lightheaded on standing two or three times a week instead of daily | S |
| Replete vitamin D to 30 ng/mL or higher | 1858-09-14 | completed | 25-hydroxyvitamin D 34 ng/mL | S |